In previous studies, researchers have observed a greater impact on T cell suppression in BM compared with that in PB in leukemia and MM patients, which was evident from the higher percentage of PD-1+/Tim-3+ T cells in the BM (4, 42, 43). This evidence concerns the gene HAVCR2 and leukemia.